BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 24853399)

  • 1. Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts.
    Hautz T; Zelger BG; Nasr IW; Mundinger GS; Barth RN; Rodriguez ED; Brandacher G; Weissenbacher A; Zelger B; Cavadas P; Margreiter R; Lee WP; Pratschke J; Lakkis FG; Schneeberger S
    Transpl Int; 2014 Sep; 27(9):966-76. PubMed ID: 24853399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of chronic rejection in a nonhuman primate model of vascularized composite allotransplantation.
    Mundinger GS; Munivenkatappa R; Drachenberg CB; Ha JS; Vaca EE; Shipley ST; Papadimitriou JC; Bartlett ST; Rodriguez ED; Barth RN
    Transplantation; 2013 May; 95(10):1204-10. PubMed ID: 23694932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
    Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
    Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
    Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells are not predictive of outcomes in a nonhuman primate model of vascularized composite allotransplantation.
    Brazio PS; Munivenkatappa RB; Bojovic B; Ha JS; Brown EN; Hess AS; Bartlett ST; Rodriguez ED; Barth RN
    Transplantation; 2013 Aug; 96(3):267-73. PubMed ID: 23839001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys.
    Xu X; Han Y; Wang Q; Cai M; Qian Y; Wang X; Huang H; Xu L; Xiao L; Shi B
    Immunol Invest; 2016; 45(1):38-51. PubMed ID: 26709668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.
    Friedman O; Carmel N; Sela M; Abu Jabal A; Inbal A; Ben Hamou M; Krelin Y; Gur E; Shani N
    PLoS One; 2017; 12(7):e0181507. PubMed ID: 28746417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scabies in a bilateral hand allograft recipient: An additional mimicker of acute skin rejection in vascularized composite allotransplantation.
    Kanitakis J; Morelon E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28211139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
    Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
    J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascularized composite allograft-specific characteristics of immune responses.
    Issa F
    Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review.
    Kauke M; Safi AF; Zhegibe A; Haug V; Kollar B; Nelms L; Palmer WJ; Tchiloemba B; Lian CG; Murphy GF; Pomahac B
    Transplantation; 2020 Dec; 104(12):2616-2624. PubMed ID: 32053572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
    Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
    Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection.
    Baddoura FK; Nasr IW; Wrobel B; Li Q; Ruddle NH; Lakkis FG
    Am J Transplant; 2005 Mar; 5(3):510-6. PubMed ID: 15707405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
    Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
    Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique immunobiology of the skin: implications for tolerance of vascularized composite allografts.
    Chadha R; Leonard DA; Kurtz JM; Cetrulo CL
    Curr Opin Organ Transplant; 2014 Dec; 19(6):566-72. PubMed ID: 25333830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing skin rejection in vascularized composite allotransplantation: advances and challenges.
    Sarhane KA; Khalifian S; Ibrahim Z; Cooney DS; Hautz T; Lee WP; Schneeberger S; Brandacher G
    Clin Transplant; 2014 Mar; 28(3):277-85. PubMed ID: 24476538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506-TyroSpheres in a Nonhuman Primate Model.
    Gama AR; Ng ZY; Shanmugarajah K; Mastroianni M; Randolph MA; Lellouch AG; Kohn J; Cetrulo CL
    J Burn Care Res; 2020 Nov; 41(6):1172-1178. PubMed ID: 32352521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
    Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
    Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants.
    Ashraf MI; Mengwasser J; Reutzel-Selke A; Polenz D; Führer K; Lippert S; Tang P; Michaelis E; Catar R; Pratschke J; Witzel C; Sauer IM; Tullius SG; Kern B
    Front Immunol; 2024; 15():1395945. PubMed ID: 38799435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.